Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Legit unveils a new collaboration software for life sciences

By Heather Hall | February 25, 2020

Legit​ announced today the launch of their new collaboration software geared towards the life sciences. This first of its kind enterprise software allows companies to identify, connect, and collaborate with internal and external experts within the life sciences.

The platform’s primary goal is to address the collaboration barriers within the life sciences caused by compliance requirements, scattered information, and lack of visibility within companies.

With over 2 mil external experts available, Legit has the largest network in the world. The platform scans over 40 million data points and uses natural language processing to find precise experts on any topic, no matter how niche. Within the Legit network of experts, companies can find doctors, academic researchers, early-stage company leaders, and seasoned executives.

While traditional expert platforms focus exclusively on external expertise, Legit is the only software that can also help companies identify internal experts. Internal experts are individuals within their company who have shown to be particularly knowledgeable in a specific area. Legit breaks down communication barriers caused by team size, mergers & acquisitions, and geographical boundaries.

As part of its breakthrough model, Legit is the first and only platform in the industry that enables companies to maximize the potential of their internal resources before investing in external solutions.

Legit offers the fastest turnaround in the industry. Once a user picks a time, Legit will streamline all logistics – whether it is legal, compliance, or scheduling, the platform manages the process. Companies connect with the right expert five times faster with Legit, compared to traditional methods.

“With an increasing number of early-stage collaborations, it has never been more vital for life sciences companies to find ways to efficiently collaborate – both internally and externally,” said Kevin Lynch, former Vice President of Search & Evaluation at AbbVie. “Yet at the same time, with the vast amount of information available and the often geographically spread sites, this continues to present a formidable challenge”.

The new version of Legit is already operating across companies like J&J Innovation and Amgen. To request a personalized demo, visit ​legit.ai/​demo

About Legit

With 15 out of the top 20 life science teams using the product, LegitTM is the industry-leading platform that helps companies discover and collaborate with experts in life sciences. Unlike traditional expert marketplaces, LegitTM powers the most successful collaborations by enabling companies to tap into internal, as well as external expertise. For more information, visit legit.ai

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE